0001672520-17-000002.txt : 20171122
0001672520-17-000002.hdr.sgml : 20171122
20171122143651
ACCESSION NUMBER: 0001672520-17-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20171122
DATE AS OF CHANGE: 20171122
EFFECTIVENESS DATE: 20171122
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Censa Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001672520
IRS NUMBER: 474109603
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-299411
FILM NUMBER: 171219639
BUSINESS ADDRESS:
STREET 1: 222 THIRD STREET, SUITE 2240
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-225-7700
MAIL ADDRESS:
STREET 1: 222 THIRD STREET, SUITE 2240
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
D
1
primary_doc.xml
X0708
D
LIVE
0001672520
Censa Pharmaceuticals Inc.
222 THIRD STREET, SUITE 2240
CAMBRIDGE
MA
MASSACHUSETTS
02142
617-225-7700
DELAWARE
None
None
Corporation
true
2015
Jonathan
Reis
c/o Censa Pharmaceuticals, Inc.
222 Third Street, Suite 2240
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Director
Chris
Schelling
c/o Censa Pharmaceuticals, Inc.
222 Third Street, Suite 2240
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Director
Joseph
Baron
c/o Censa Pharmaceuticals, Inc.
222 Third Street, Suite 2240
Cambridge
MA
MASSACHUSETTS
02142
Director
Pini
Orbach
c/o Censa Pharmaceuticals, Inc.
222 Third Street, Suite 2240
Cambridge
MA
MASSACHUSETTS
02142
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2017-11-17
false
true
true
false
20000
1500000
1500000
0
false
18
0
0
100000
false
Censa Pharmaceuticals Inc.
/s/Jonathan Reis
Jonathan Reis
Chief Executive Officer
2017-11-21